NX Netherlands Receives IATA CEIV Pharma Certification for Its Warehouse Near Amsterdam Airport Schiphol

February 01, 2024 05:00 PM AEDT | By Cision

NX Netherlands Receives IATA CEIV Pharma Certification for Its Warehouse Near Amsterdam Airport Schiphol — Image source: Kalkine Media

Recent News

Prosperity Of Life Celebrates Transformational Success — A Lifelong Ed...

Netstar Lifestyle Magazine Commence Features On Car Park Safety Soluti...

Gabe McDaniel Releases Debut EP, 'Like We Mean It' — A Gritty, Soulful...

Southwire Named to America’s Greatest Workplaces for Women 2025 Rankin...

TOKYO, Feb. 1, 2024 /PRNewswire/ -- Nippon Express (Nederland) B.V. (hereinafter "NX Netherlands"), a group company of NIPPON EXPRESS HOLDINGS, INC., has acquired CEIV Pharma certification (*), a quality certification for pharmaceutical transport established by the International Air Transport Association (IATA), for its warehouse facility in Schiphol Trade Park near Amsterdam Airport Schiphol in the Netherlands, effective December 7, 2023.

Logo: https://kyodonewsprwire.jp/img/202401295862-O1-iSqLngC2

Exterior view of warehouse: https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202401295862/_prw_PI2fl_K8ND1iwS.jpg

Interior view of CEIV Pharma-certified warehouse: https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202401295862/_prw_PI3fl_slVnxK8s.jpg

The Netherlands is home to a cluster of some of the most advanced biotechnology companies in Europe, and many pharmaceutical manufacturers have concentrated their distribution centers in the Netherlands due to its geographical and tax advantages.

The Nippon Express (hereinafter "NX") Group has positioned the pharmaceutical industry as a key industry and is pursuing the global development of a safe and secure pharmaceutical logistics platform to meet the ever more sophisticated and diverse needs of the pharmaceutical logistics industry. NX Netherlands had already received Good Distribution Practice (GDP) certification in September 2021, evidencing its compliance with internationally recognized standards for the proper distribution of pharmaceuticals, and, with the acquisition of CEIV Pharma certification, will now be able to provide safer and higher-quality pharmaceutical transportation services in the Netherlands, an important hub for the pharmaceutical industry.

The NX Group is committed to contributing to the health of people around the world by supporting its customers in the global pharmaceutical industry from a logistics perspective through the establishment of a reliable and safe global pharmaceutical logistics platform.

(*) CEIV Pharma (The Center of Excellence for Independent Validators in Pharmaceutical Logistics): a quality certification program established by the International Air Transport Association (IATA) to cover the air transport of pharmaceutical products that sets out high standards encompassing the differing Good Distribution Practice (GDP) guidelines of countries around the world for the storage and transport of pharmaceuticals

Nippon Express website: https://www.nipponexpress.com/

Nippon Express Group's official LinkedIn account: https://www.linkedin.com/company/nippon-express-group/

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.